补充二十碳五烯酸预防动脉粥样硬化性心血管疾病 - Suppr | 超能文献

Eicosapentanoic Acid Supplementation for Atherosclerotic Cardiovascular Disease Prevention.

作者信息

Bittner Vera

机构信息

Division of Cardiovascular Disease, University of Alabama at Birmingham.

出版信息

Circulation. 2024 Aug 6;150(6):435-438. doi: 10.1161/CIRCULATIONAHA.124.069881. Epub 2024 Aug 5.

DOI:10.1161/CIRCULATIONAHA.124.069881

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Eicosapentanoic Acid Supplementation for Atherosclerotic Cardiovascular Disease Prevention.补充二十碳五烯酸预防动脉粥样硬化性心血管疾病

Circulation. 2024 Aug 6;150(6):435-438. doi: 10.1161/CIRCULATIONAHA.124.069881. Epub 2024 Aug 5.

2

Eicosapentaenoic acid (EPA): an antiinflammatory omega-3 fat with potential clinical applications.

Nutrition. 2000 Nov-Dec;16(11-12):1116-8. doi: 10.1016/s0899-9007(00)00392-0.

3

The eicosapentaenoic acid:arachidonic acid ratio and its clinical utility in cardiovascular disease.二十碳五烯酸：花生四烯酸比值及其在心血管疾病中的临床应用。

Postgrad Med. 2019 May;131(4):268-277. doi: 10.1080/00325481.2019.1607414. Epub 2019 May 7.

4

Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid.降低欧洲剩余心血管风险：欧洲药品管理局批准依泽替米贝/二十碳五烯酸的治疗意义。

Pharmacol Ther. 2022 Sep;237:108172. doi: 10.1016/j.pharmthera.2022.108172. Epub 2022 Mar 15.

5

Icosapent ethyl: drug profile and evidence of reduced residual cardiovascular risk in patients with statin-managed LDL-C cholesterol.二十碳五烯酸乙酯：他汀类药物控制低密度脂蛋白胆固醇患者的药物概况及降低残余心血管风险的证据

Expert Rev Cardiovasc Ther. 2020 Apr;18(4):175-180. doi: 10.1080/14779072.2020.1749596. Epub 2020 Apr 6.

6

Spotlight on Icosapent Ethyl for Cardiovascular Risk Reduction: Evidence to Date.二十碳五烯酸乙酯降低心血管风险的研究聚焦：迄今的证据

Vasc Health Risk Manag. 2020 Jan 9;16:1-10. doi: 10.2147/VHRM.S210149. eCollection 2020.

7

Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.ω-3 脂肪酸对冠状动脉血运重建和心血管事件的影响：一项荟萃分析。

Eur J Prev Cardiol. 2024 Nov 11;31(15):1863-1875. doi: 10.1093/eurjpc/zwae184.

8

A randomized clinical trial on n-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk.一项关于补充n-3多不饱和脂肪酸与心血管高风险老年男性全因死亡率的随机临床试验。

Eur J Cardiovasc Prev Rehabil. 2010 Oct;17(5):588-92. doi: 10.1097/HJR.0b013e328339cc70.

9

JCL roundtable: Omega-3 fatty acids and cardiovascular outcomes.JCL 圆桌会议：欧米伽-3 脂肪酸与心血管结局

J Clin Lipidol. 2020 Jan-Feb;14(1):4-15. doi: 10.1016/j.jacl.2020.02.004.

10

Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.用于心血管疾病一级和二级预防的欧米伽-3脂肪酸

Cochrane Database Syst Rev. 2020 Feb 29;3(3):CD003177. doi: 10.1002/14651858.CD003177.pub5.

引用本文的文献

1

Metabolic profiling reveals altered amino acid and fatty acid metabolism in children with Williams Syndrome.代谢谱分析揭示了威廉姆斯综合征患儿氨基酸和脂肪酸代谢的改变。

Sci Rep. 2024 Dec 28;14(1):31467. doi: 10.1038/s41598-024-83146-4.